Physician profile
John Day
NPI 1295738227
$4,840.40
in general payments reported to CMS, 2019-2025
16 companies · $1,589 in 2025
The $1,589 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $466 · 2021: $151 · 2022: $1,069 · 2023: $314 · 2024: $904 · 2025: $1,589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,807.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,905.96 | 2019-2025 | Mymobility Platform, Accufill, Rosa |
| Stryker Corporation | $1,105.95 | 2022-2025 | Aequalis Perform, Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed |
| Becton, Dickinson and Company | $355.40 | 2024 | Arista Ah Flexitip |
| Ferring Pharmaceuticals INC. | $174.30 | 2021-2025 | Euflexxa |
| Medical Device Business Services, INC. | $82.00 | 2023 | Inhance |
| Depuy Synthes Sales INC. | $61.04 | 2019 | |
| Boston Scientific Corporation | $39.08 | 2023-2025 | General - Pain Management |
| Sanara Medtech INC. | $24.17 | 2024 | Celleraterx |
| Smith+Nephew, INC. | $17.64 | 2023 | |
| Orthogenrx INC. | $16.40 | 2021 | |
| Horizon Therapeutics Plc | $15.74 | 2020 | |
| Pacira Therapeutics, INC. | $12.84 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $12.80 | 2020 | |
| Orthofix Medical, INC. | $10.62 | 2019 | |
| Heraeus Medical, LLC. | $6.46 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.